Marek Nowak

1.2k total citations
56 papers, 954 citations indexed

About

Marek Nowak is a scholar working on Reproductive Medicine, Immunology and Oncology. According to data from OpenAlex, Marek Nowak has authored 56 papers receiving a total of 954 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Reproductive Medicine, 16 papers in Immunology and 12 papers in Oncology. Recurrent topics in Marek Nowak's work include Ovarian cancer diagnosis and treatment (22 papers), Endometriosis Research and Treatment (12 papers) and Reproductive System and Pregnancy (7 papers). Marek Nowak is often cited by papers focused on Ovarian cancer diagnosis and treatment (22 papers), Endometriosis Research and Treatment (12 papers) and Reproductive System and Pregnancy (7 papers). Marek Nowak collaborates with scholars based in Poland, United States and Germany. Marek Nowak's co-authors include Magdalena Klink, M Szpakowski, Jacek R. Wilczyński, Krzysztof Szyłło, Zofia Sułowska, Gerhard Schüler, Georg Fuernau, Steffen Desch, Ingo Eitel and Lysann Hildebrand and has published in prestigious journals such as Journal of the American College of Cardiology, American Heart Journal and Medicine.

In The Last Decade

Marek Nowak

53 papers receiving 926 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marek Nowak Poland 14 303 289 206 187 183 56 954
Yuko Sugiyama Japan 14 70 0.2× 244 0.8× 346 1.7× 153 0.8× 142 0.8× 62 968
Irma Isordia‐Salas Mexico 22 363 1.2× 262 0.9× 62 0.3× 131 0.7× 18 0.1× 81 1.4k
Liyun Cao United States 14 80 0.3× 350 1.2× 279 1.4× 133 0.7× 71 0.4× 25 945
Muh‐Hwa Yang Taiwan 16 186 0.6× 465 1.6× 456 2.2× 245 1.3× 196 1.1× 56 1.3k
Keiko Nishida Japan 17 223 0.7× 284 1.0× 253 1.2× 44 0.2× 40 0.2× 58 931
B D Evans New Zealand 11 118 0.4× 217 0.8× 362 1.8× 107 0.6× 41 0.2× 24 728
Juhani Mäenpää Finland 17 68 0.2× 175 0.6× 201 1.0× 137 0.7× 305 1.7× 75 943
Steven J. Oosterling Netherlands 20 255 0.8× 179 0.6× 747 3.6× 104 0.6× 49 0.3× 42 1.3k

Countries citing papers authored by Marek Nowak

Since Specialization
Citations

This map shows the geographic impact of Marek Nowak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Nowak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Nowak more than expected).

Fields of papers citing papers by Marek Nowak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek Nowak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Nowak. The network helps show where Marek Nowak may publish in the future.

Co-authorship network of co-authors of Marek Nowak

This figure shows the co-authorship network connecting the top 25 collaborators of Marek Nowak. A scholar is included among the top collaborators of Marek Nowak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marek Nowak. Marek Nowak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nowak, Marek, et al.. (2023). Rapidly growing uterine myoma – should we be afraid of it?. Menopausal Review. 22(3). 161–164.
2.
Wilczyński, Miłosz, et al.. (2018). Clinical significance of miRNA-21, -103, -129, -150 in serous ovarian cancer. Archives of Gynecology and Obstetrics. 297(3). 741–748. 10 indexed citations
3.
Bednarska, Katarzyna, Ewa Król, Ewa Głowacka, et al.. (2018). Analysis of preoperative blood platelet parameters in terms of diversity of epithelial ovarian cancer. Medicine. 97(12). e0180–e0180. 4 indexed citations
4.
Wilczyński, Miłosz, et al.. (2017). Expression of miR-146a in patients with ovarian cancer and its clinical significance. Oncology Letters. 14(3). 3207–3214. 28 indexed citations
5.
Nowak, Marek, Ewa Głowacka, Przemysław Lewkowicz, et al.. (2017). Sub-optimal primary surgery leads to unfavorable immunological changes in ovarian cancer patients. Immunobiology. 223(1). 1–7. 7 indexed citations
6.
Kiełbik, Michał, Izabela Szulc-Kiełbik, Marek Nowak, Zofia Sułowska, & Magdalena Klink. (2016). Evaluation of nitric oxide donors impact on cisplatin resistance in various ovarian cancer cell lines. Toxicology in Vitro. 36. 26–37. 8 indexed citations
7.
Nowak, Marek, Ewa Głowacka, Michał Kiełbik, et al.. (2016). Secretion of cytokines and heat shock protein (HspA1A) by ovarian cancer cells depending on the tumor type and stage of disease. Cytokine. 89. 136–142. 10 indexed citations
8.
Wilczyński, Jacek R., et al.. (2016). The significance of markers in the diagnosis of endometrial cancer. Menopausal Review. 3(3). 176–185. 11 indexed citations
9.
Stachowiak, Grzegorz, et al.. (2015). Hemostatic disorders of the menopausal period: the role of microRNA. Menopausal Review. 2(2). 144–148. 6 indexed citations
11.
Kiełbik, Michał, Izabela Szulc-Kiełbik, Katarzyna Bednarska, et al.. (2014). Nitric oxide donors reduce the invasion ability of ovarian cancer cells in vitro. Anti-Cancer Drugs. 25(10). 1141–1151. 15 indexed citations
12.
Litwińska, Ewelina, et al.. (2014). Vaginal hysterectomy vs. laparoscopically assisted vaginal hysterectomy in women with symptomatic uterine leiomyomas: a retrospective study. Menopausal Review. 4(4). 242–246. 3 indexed citations
13.
Klink, Magdalena, Michał Kiełbik, Marek Nowak, Katarzyna Bednarska, & Zofia Sułowska. (2012). JAK3, STAT3 and CD3-zeta Signaling Proteins Status in Regard to the Lymphocytes Function in Patients with Ovarian Cancer. Immunological Investigations. 41(4). 382–398. 11 indexed citations
15.
Klink, Magdalena, Marek Nowak, Katarzyna Bednarska, et al.. (2008). Ovarian Cancer Cells Modulate Human Blood Neutrophils Response to Activation In Vitro. Scandinavian Journal of Immunology. 68(3). 328–336. 42 indexed citations
16.
Nowak, Marek, et al.. (2007). The value of different forms of compression therapy in the treatment of iatrogenic femoral pseudoaneurysms. 13(2). 75–84. 1 indexed citations
17.
Malinowski, Andrzej, Marek Nowak, Jacek R. Wilczyński, et al.. (2003). [Influence of paternal lymphocyte immunization on the selected subpopulations of peripheral blood lymphocytes in women with recurrent spontaneous abortions of unknown etiology].. PubMed. 74(4). 288–96. 8 indexed citations
18.
Malinowski, Andrzej, et al.. (2001). [The place of laparoscopy in gynecological practice--useful technique for diagnostic and treatment of infertility and endometriosis].. PubMed. 72(12A). 1347–54. 1 indexed citations
19.
Nowak, Marek, et al.. (1998). [Intrauterine infections. I. The role of C-reactive protein, white blood cell count and erythrocyte sedimentation rate in pregnant women in the detection of intrauterine infection after preliminary rupture of membranes].. PubMed. 69(8). 615–22. 17 indexed citations
20.
Warwas, Maria, et al.. (1997). Cathepsin B-Like Activity as a Serum Tumour Marker in Ovarian Carcinoma. Clinical Chemistry and Laboratory Medicine (CCLM). 35(4). 301–4. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026